Repligen expands process analytics portfolio with DRS Daylight Solutions agreement
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership ...
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership ...
Forget walking 10,000 steps a day. Taking at least 50 steps climbing stairs each day could significantly slash your risk...
Read moreExamples of mismatched materials of varying thermal dynamics, cured at various temperatures, causing warpage, cracking and potential breakage. The results...
Read moreA new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten...
Read moreAmbu CEO Britt Meelby Jensen Ambu’s CEO seeks to “Zoom In” on what the Danish company has done best. More...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.